患者参与HOPE试验的设计与实施:关注血液透析患者的慢性疼痛
HOPE联盟试验是一项由美国国立糖尿病、消化和肾脏疾病研究所资助的随机对照试验,旨在减少血液透析患者的疼痛与阿片类药物使用。患者顾问参与了研究设计、招募材料开发及全部委员会工作,其参与对研究成功入组和保留受试者至关重要,并提升了患者顾问的满意度与后续领导力发展。
要点
- 患者顾问全程参与HOPE试验设计、招募及所有委员会工作,被视作平等伙伴。
- 患者顾问的参与对研究成功入组和保留受试者起到关键作用。
- 患者顾问对参与体验评价积极,部分顾问后续承担了其他研究或倡导角色。
核心结论
- 患者顾问为研究设计与实施做出重要贡献,其参与对HOPE试验成功入组和保留受试者至关重要。
- 患者顾问将参与体验的满意度归因于全面融入研究各方面并被作为平等伙伴对待。
研究设计与样本
- HOPE联盟试验是一项由美国国立糖尿病、消化和肾脏疾病研究所资助的随机对照试验。
- 受试者为患有慢性疼痛的血液透析患者,随机接受常规护理或由受训教练远程提供的12周疼痛应对技能培训,随后通过交互式语音应答进行12周技能强化。
- 患者顾问参与研究所有阶段,包括研究设计和招募材料开发;试验期间每月作为顾问委员会开会,并参与所有指导委员会会议(包括面对面会议和每两周一次的远程会议)。
- 患者顾问代表参与所有研究委员会,在招募与保留委员会中参与尤为广泛。
主要发现
- 患者顾问为研究设计与实施做出重要贡献,其参与对研究成功入组和保留受试者至关重要。
- 患者顾问对参与体验评价积极,将满意度归因于全面融入研究各方面并被作为平等伙伴对待。
- 若干患者顾问随后承担了其他研究、患者倡导或领导角色,部分得益于参与HOPE试验。
临床怎么用
- 本研究详述了患者顾问被招募和决定参与的方式,概述了他们的诸多贡献,描述了他们的体验,并为研究人员如何成功将患者顾问纳入未来研究提供了指导。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis was a randomized, controlled trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases. Patients on hemodialysis suffering from chronic pain were randomly assigned to receive usual care or a 12-week pain coping skills training program delivered remotely by trained coaches followed by 12 weeks of skills reinforcement via interactive voice response. Patient advisors participated in all stages of the study, including study design and development of recruitment materials. During the trial, patient advisors met monthly as an Advisory Board. In addition, patient advisors participated in all Steering Committee meetings, including in-person meetings and biweekly remote meetings. Patient advisors were represented on all study committees, with particularly extensive involvement in the Recruitment and Retention Committee. Patient advisors made important contributions to study design and conduct. Their involvement was critical to the study's successful enrollment and retention of study participants. Patient advisors characterized their involvement positively. They attributed their satisfaction with the experience to their full integration into in all aspects of the study and their treatment as equal partners. Several patient advisors have subsequently taken on other research, patient advocacy, or leadership roles, facilitated in part through their participation in the HOPE Trial. This study details the ways patient advisors were enlisted and decided to participate; outlines their many contributions; describes their experience; and provides guidance on how researchers can successfully incorporate patient advisors into future studies.
引用
- White DM, Kimmel PL, Dember LM, et al. Patient Engagement in the Design and Conduct of the HOPE Trial: Addressing Chronic Pain in Hemodialysis Patients. Clin J Am Soc Nephrol. 2025. PMID: 40824757. doi:10.2215/CJN.0000000866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。